PRODUCTS / BROCA DIALECTICAL IMPLANT
MEDICAL DEVICE

BROCA DIALECTICAL
IMPLANT

INSTANT LANGUAGE ACQUISITION THROUGH DIRECT NEURAL INTERFACE. NO STUDY. NO COURSES. NO DELAY. FULL FLUENCY IN ANY SUPPORTED LANGUAGE WITHIN 72 HOURS OF IMPLANTATION.

2060
YEAR INTRODUCED
72 HRS
TIME TO FLUENCY
48+
SUPPORTED LANGUAGES
FDA
APPROVED
OVERVIEW

HOW IT WORKS

THE BROCA DIALECTICAL IMPLANT INTERFACES DIRECTLY WITH THE BRAIN'S LANGUAGE CENTERS, SPECIFICALLY BROCA'S AREA AND WERNICKE'S AREA, TO ENABLE RAPID LANGUAGE ACQUISITION WITHOUT TRADITIONAL LEARNING. THE DEVICE MAPS NATIVE LINGUISTIC NEURAL PATHWAYS AND CONSTRUCTS PARALLEL PATHWAYS FOR EACH TARGET LANGUAGE.

01

NEURAL MAPPING

PRE-PROCEDURE SCAN MAPS THE PATIENT'S EXISTING LINGUISTIC NEURAL ARCHITECTURE. MEDPOD 720I GENERATES A COMPLETE NEURAL TOPOLOGY MODEL.

02

IMPLANTATION

THE DEVICE IS PLACED VIA MINIMALLY INVASIVE PROCEDURE. THE MEDPOD POSITIONS THE IMPLANT AT THE JUNCTION OF BROCA'S AND WERNICKE'S AREAS WITH SUB-MILLIMETER PRECISION.

03

INTEGRATION

OVER 48-72 HOURS, THE IMPLANT ESTABLISHES CONNECTIONS WITH THE PATIENT'S NEURAL PATHWAYS. LANGUAGE DATA IS LOADED FROM THE ONBOARD LINGUISTIC DATABASE.

04

ACTIVATION

FULL FLUENCY IS ACHIEVED. THE PATIENT CAN COMPREHEND AND PRODUCE SPEECH IN ALL LOADED LANGUAGES. ADDITIONAL LANGUAGES CAN BE ADDED VIA UPDATE.

SPECIFICATIONS

TECHNICAL DATA

DEVICE
DIMENSIONS 14MM x 8MM x 3MM
WEIGHT 2.4 GRAMS
MATERIAL BIOCOMPATIBLE TITANIUM / CARBON NANOTUBE
POWER SOURCE BIOENERGETIC (SELF-SUSTAINING)
SERVICE LIFE PERMANENT (NO REPLACEMENT REQUIRED)
CAPABILITIES
LANGUAGES SUPPORTED 48 (EXPANDABLE VIA UPDATE)
SIMULTANEOUS ACTIVE UP TO 12 LANGUAGES
FLUENCY LEVEL NATIVE-EQUIVALENT (C2+)
ACTIVATION TIME 48-72 HOURS POST-IMPLANTATION
UPDATE METHOD MEDPOD WIRELESS / NON-INVASIVE
PROCEDURE

IMPLANTATION PROTOCOL

>
PRE-OPERATIVE ASSESSMENT FULL NEURAL SCAN VIA MEDPOD. LANGUAGE CENTER MAPPING. PATIENT HISTORY REVIEW. APPROXIMATELY 45 MINUTES.
>
IMPLANTATION MINIMALLY INVASIVE PROCEDURE PERFORMED BY MEDPOD 720I. LOCAL ANESTHESIA. PROCEDURE TIME: 90 MINUTES. OUTPATIENT.
>
INTEGRATION PERIOD 48-72 HOURS. PATIENT MAY EXPERIENCE MILD HEADACHE AND AUDITORY PROCESSING CHANGES. MONITORED VIA MEDPOD REMOTE TELEMETRY.
>
POST-OPERATIVE VERIFICATION FLUENCY TESTING IN ALL LOADED LANGUAGES. NEURAL PATHWAY STABILITY CONFIRMATION. FOLLOW-UP AT 30 AND 90 DAYS.

REGULATORY APPROVALS

> FDA CLEARED: CLASS III MEDICAL DEVICE (2060)
> ICC MEDICAL DEVICE AUTHORIZATION
> COLONIAL MEDICAL STANDARDS BOARD CERTIFIED
> ISO 13485 MEDICAL DEVICE QMS
> ICC NEURAL DEVICE SAFETY STANDARD (NDSS-7)

CONTRAINDICATIONS

> PATIENTS UNDER 16 YEARS OF AGE
> ACTIVE NEUROLOGICAL CONDITIONS
> PRIOR NEURAL IMPLANT INCOMPATIBILITY
> PREGNANCY (DEFER TO POSTPARTUM)
> SEVERE ALLERGIES TO TITANIUM COMPOUNDS

SUPPORTED LANGUAGES

CURRENT LIBRARY INCLUDES ALL MAJOR EARTH LANGUAGES AND THE FOLLOWING SPECIALIZED MODULES:

> TECHNICAL ENGINEERING TERMINOLOGY
> MEDICAL AND SCIENTIFIC VOCABULARY
> LEGAL AND REGULATORY LANGUAGE
> COLONIAL DIALECT PACKAGES
> MILITARY AND SECURITY PROTOCOLS

REQUEST A CONSULTATION

CONTACT OUR MEDICAL DEVICES TEAM TO DISCUSS ELIGIBILITY, PROCEDURE SCHEDULING, AND INSTITUTIONAL DEPLOYMENT OPTIONS.